Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice

Fig. 1

Short-duration treatment with Dasatinib reduced adiposity in the heart and bone marrow of db/db mice. (A) Cartoon of the experimental protocol. (B-E) Bar graphs showing the data of echocardiography about stroke volume (SV), ejection fraction (EF), cardiac index (CI) and E/A ratio. Illustrative images (F) and quantification (G) of ORO staining of the heart. Illustrative images (H) and quantification (I) of ORO staining of the bone marrow. Bar graphs show individual values and means ± SEM. n = 4 animals per group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840